KRAS

You have access
Growth Suppression of Cancer Spheroids With Mutated KRAS by Low-toxicity Compounds from Natural Products
SAYURI HASHIMOTO, MASAYOSHI NAGAI, KENSUKE NISHI, SHUHEI ISHIKURA, KAZUHIKO NAKABAYASHI, RYO YAZAKI, TAKASHI OHSHIMA, MASAHIKO SUENAGA, SENJI SHIRASAWA and TOSHIYUKI TSUNODA

Anticancer Research August 2021, 41 (8) 4061-4070; DOI: https://doi.org/10.21873/anticanres.15207
You have access
Radiogenomic and Deep Learning Network Approaches to Predict KRAS Mutation from Radiotherapy Plan CT
BUM-SUP JANG, CHANGHOON SONG, SUNG-BUM KANG and JAE-SUNG KIM

Anticancer Research August 2021, 41 (8) 3969-3976; DOI: https://doi.org/10.21873/anticanres.15193
You have access
Mutant KRAS Promotes NKG2D⁺ T Cell Infiltration and CD155 Dependent Immune Evasion
KENSUKE NISHI, SHUHEI ISHIKURA, MASAYO UMEBAYASHI, TAKASHI MORISAKI, TAKASHI INOZUME, TETSUSHI KINUGASA, MIKIKO AOKI, SATOSHI NIMURA, ANTHONY SWAIN, YOICHIRO YOSHIDA, SUGURU HASEGAWA, KAZUKI NABESHIMA, TOSHIFUMI SAKATA, SENJI SHIRASAWA and TOSHIYUKI TSUNODA

Anticancer Research August 2020, 40 (8) 4663-4674; DOI: https://doi.org/10.21873/anticanres.14465
You have access
MK615 Suppresses Hypoxia Tolerance by Up-regulation of E-cadherin in Colorectal Cancer Cells With Mutant KRAS
KENSUKE NISHI, TOSHIYUKI TSUNODA, YOSHINORI UCHIDA, TAKAYUKI SUETA, MOTOHIRO SAWATSUBASHI, TAKAFUMI YAMANO, YASUKO HASHIGUCHI, ANTHONY SWAIN, SENJI SHIRASAWA and TOSHIFUMI SAKATA

Anticancer Research August 2020, 40 (8) 4687-4694; DOI: https://doi.org/10.21873/anticanres.14468
You have access
Secretin-induced Duodenal Aspirate of Pancreatic Juice (SIDA): Utility of Commercial Genetic Analysis
RACHEL E. SIMPSON, MICHELE YIP-SCHNEIDER, KATELYN F. FLICK, MAZHAR SOUFI, EUGENE P. CEPPA, MOHAMMAD A. AL-HADDAD, JEFFREY J. EASLER, STUART SHERMAN, JOHN M. DEWITT and C. MAX SCHMIDT

Anticancer Research August 2020, 40 (8) 4215-4221; DOI: https://doi.org/10.21873/anticanres.14422
You have access
Efficacy of Anti-PD1/PD-L1 Therapy (IO) in KRAS Mutant Non-small Cell Lung Cancer Patients: A Retrospective Analysis
LETIZIA GIANONCELLI, GIANLUCA SPITALERI, ANTONIO PASSARO, DAVIDE RADICE, CATERINA FUMAGALLI, ESTER DEL SIGNORE, VALERIA STATI, CHIARA MATILDE CATANIA, ELENA GUERINI-ROCCO, MASSIMO BARBERIS and FILIPPO DE MARINIS

Anticancer Research January 2020, 40 (1) 427-433; DOI: https://doi.org/10.21873/anticanres.13970
You have access
Microsatellite Instability in Greek Colorectal Carcinoma Patients: Clinicopathological and Molecular Correlations
PATROKLOS KATAFYGIOTIS, STRATIGOULA SAKELLARIOU, ILENIA CHATZIANDREOU, IOANNA GIANNOPOULOU, IRENE THYMARA, ANGELICA A. SAETTA and PENELOPE KORKOLOPOULOU

Anticancer Research November 2019, 39 (11) 6379-6387; DOI: https://doi.org/10.21873/anticanres.13851
You have access
The Role of KRAS in Endometrial Cancer: A Mini-Review
MICHAIL SIDERIS, ELIF ILIRIA EMIN, ZIENA ABDULLAH, JOHN HANRAHAN, KONSTANTINA MARIA STEFATOU, VASILEIOS SEVAS, ECE EMIN, TONY HOLLINGWORTH, FUNLAYO ODEJINMI, SAVVAS PAPAGRIGORIADIS, SOTIRIS VIMPLIS and FREDRIC WILLMOTT

Anticancer Research February 2019, 39 (2) 533-539; DOI: https://doi.org/10.21873/anticanres.13145
You have access
Growth Suppression of Human Colorectal Cancer Cells with Mutated KRAS by 3-Deaza-cytarabine in 3D Floating Culture
HAO LUO, KENSUKE NISHI, SHUHEI ISHIKURA, ANTHONY SWAIN, NAOYUKI MORISHIGE, RYO YAZAKI, TAKASHI OHSHIMA, SENJI SHIRASAWA and TOSHIYUKI TSUNODA

Anticancer Research July 2018, 38 (7) 4247-4256; DOI: https://doi.org/10.21873/anticanres.12721
You have access
Clinicopathological Characteristics and KRAS Mutation Status of Endometrial Mucinous Metaplasia and Carcinoma
JI-YOUN SUNG, YOON YANG JUNG and HYUN-SOO KIM

Anticancer Research May 2018, 38 (5) 2779-2786;

Main menu

User menu

Search

KRAS

Pages